[go: up one dir, main page]

NO903455L - Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav. - Google Patents

Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.

Info

Publication number
NO903455L
NO903455L NO90903455A NO903455A NO903455L NO 903455 L NO903455 L NO 903455L NO 90903455 A NO90903455 A NO 90903455A NO 903455 A NO903455 A NO 903455A NO 903455 L NO903455 L NO 903455L
Authority
NO
Norway
Prior art keywords
hormon
lute
analogs
inhibiting
preparation
Prior art date
Application number
NO90903455A
Other languages
English (en)
Other versions
NO903455D0 (no
Inventor
Fortuna Haviv
Jonathan Greer
Original Assignee
Tap Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceuticals Inc filed Critical Tap Pharmaceuticals Inc
Publication of NO903455D0 publication Critical patent/NO903455D0/no
Publication of NO903455L publication Critical patent/NO903455L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nye "pseudo" nonapeptid og decapeptidderivater av LHRH. Mer spesielt beskrives derivater av LHRH hvor nitrogenatomet av minst en av amidbindingene har blitt alkylert.
NO90903455A 1989-08-07 1990-08-06 Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav. NO903455L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39057289A 1989-08-07 1989-08-07
US07/548,512 US5110904A (en) 1989-08-07 1990-07-10 Lhrh analogs

Publications (2)

Publication Number Publication Date
NO903455D0 NO903455D0 (no) 1990-08-06
NO903455L true NO903455L (no) 1991-02-08

Family

ID=27013204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903455A NO903455L (no) 1989-08-07 1990-08-06 Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.

Country Status (12)

Country Link
US (1) US5110904A (no)
EP (1) EP0413209A1 (no)
JP (1) JPH03101695A (no)
KR (1) KR0144144B1 (no)
AU (2) AU6028690A (no)
CA (1) CA2022444C (no)
HU (1) HUT54387A (no)
IE (1) IE902740A1 (no)
IL (1) IL95136A0 (no)
NO (1) NO903455L (no)
PL (1) PL286388A1 (no)
PT (1) PT94924B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
US5352796A (en) * 1989-10-30 1994-10-04 The Salk Institute For Biological Studies Amino acids useful in making GnRH analogs
EP0477499B1 (de) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Gonadoliberin-Antagonisten
US5744450A (en) 1991-03-14 1998-04-28 The Salk Institute For Biological Studies GnRH analogs
EP0593491B1 (en) * 1991-04-25 1996-10-23 DEGHENGHI, Romano Luteinizing hormone releasing hormone antagonist peptides
EP0592512A1 (en) * 1991-07-01 1994-04-20 University Technologies International Inc. (Uti) NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
CA2136078A1 (en) * 1992-12-04 1994-06-23 Jonathan Greer 6-position modified decapeptide lhrh antagonists
UA61046C2 (en) * 1992-12-07 2003-11-17 Takeda Chemical Industries Ltd Sustained-release preparation and method for its manufacture
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
IL108509A0 (en) * 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
EP0738154A1 (en) * 1993-08-06 1996-10-23 Abbott Laboratories N-terminus modified analogs of lhrh
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5594091A (en) * 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US5508383A (en) * 1994-03-09 1996-04-16 Tap Holdings Inc. Cyclic peptide LHRH antagonists
US5516759A (en) * 1994-12-08 1996-05-14 Tap Holdings Inc. LHRH antagonists having lactam groups at the N-terminus
US5681928A (en) * 1994-12-16 1997-10-28 The Salk Institute For Biological Studies Betides and methods for screening peptides using same
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US6191115B1 (en) 1998-08-12 2001-02-20 Abbott Laboratories C-terminus modified heptapeptide LHRH analogs
US6297354B1 (en) 1998-08-12 2001-10-02 Abbott Laboratories Pentapeptide LHRH antagonists
US5981521A (en) * 1998-11-13 1999-11-09 Abbott Laboratories Tetrahydroisoquinoline derivatives as LHRH antagonists
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US6673352B1 (en) * 1999-09-14 2004-01-06 The General Hospital Corporation Use of Mullerian inhibiting substance for treating excess androgen states
BR0109279A (pt) * 2000-03-14 2002-12-17 Zentaris Ag Antagonistas de lhrh, sua preparação e aplicação como medicamento
WO2002002144A1 (fr) 2000-07-05 2002-01-10 Takeda Chemical Industries, Ltd. Preparations medicinales pour le traitement des maladies dependant des hormones sexuelles
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
EP1408876A4 (en) * 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
US7812044B2 (en) 2001-11-13 2010-10-12 Takeda Pharmaceutical Company Limited Anticancer agents
CA2478827A1 (en) * 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Remedies for sex hormone-dependent disease
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
US20040151693A1 (en) * 2002-08-23 2004-08-05 The General Hospital Corporation Use of mullerian inhibiting substance and interferon for treating tumors
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
JP5241507B2 (ja) 2006-11-30 2013-07-17 武田薬品工業株式会社 環状アミン化合物
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
PL2552424T3 (pl) 2010-04-01 2018-10-31 Chiesi Farmaceutici S.P.A. Sposób wytwarzania cząstek nośnika do suchych proszków do inhalacji
US20130177651A1 (en) 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
WO2014010614A1 (ja) 2012-07-12 2014-01-16 武田薬品工業株式会社 マイクロカプセル粉末の製造方法
WO2018085495A2 (en) 2016-11-02 2018-05-11 Board Of Regents, The University Of Texas System Dissolvable films and methods of their use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4493934A (en) * 1979-10-01 1985-01-15 Merck & Co., Inc. 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0328090A3 (en) * 1988-02-10 1990-08-16 Abbott Laboratories Lhrh analogs
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists

Also Published As

Publication number Publication date
PT94924B (pt) 1997-09-30
AU672474B2 (en) 1996-10-03
US5110904A (en) 1992-05-05
AU5789294A (en) 1994-05-26
JPH03101695A (ja) 1991-04-26
EP0413209A1 (en) 1991-02-20
PL286388A1 (en) 1991-05-06
NO903455D0 (no) 1990-08-06
KR910004661A (ko) 1991-03-29
HUT54387A (en) 1991-02-28
CA2022444C (en) 2002-01-15
AU6028690A (en) 1991-02-07
CA2022444A1 (en) 1991-02-08
IL95136A0 (en) 1991-06-10
KR0144144B1 (ko) 1998-07-01
PT94924A (pt) 1991-05-22
IE902740A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
NO903455L (no) Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.
MXPA99001870A (es) Antagonistas del receptor de taquicinina,no peptidicos.
AU540766B2 (en) Nonapeptide and decapeptide analogs of lhrh
MX9705273A (es) Inhibidores de prenil transferasas.
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
DK0831100T3 (da) Nye peptidderivater
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
TW334436B (en) Antiparasitic marcfortines and paraherquamides
EE9800173A (et) Gonadotropiini riliisinghormooni antagonistid
PT817847E (pt) Receptor de il-17
HUP9800840A3 (en) Substituted oximes, hydrazones and olefins with saturated, nitrogen containing heterocyclic rings as neurokinin antagonists and pharmaceutical compositions containing them
UA41287C2 (uk) Алкоголяти металів для отримання похідних таксану
HUP0100353A2 (hu) Urokináz inhibitor hatású naftamidinszármazékok
MX9304698A (es) Heterociclos que contienen nitrogeno substituido.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
DE69419623D1 (de) Peptidinhibitoren der urokinaserezeptor-aktivität
NO933524D0 (no) Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav
EP0328090A3 (en) Lhrh analogs
NO302072B1 (no) Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og preparater inneholdende slike
ZA945246B (en) Novel 9-N-Bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
MY105128A (en) Bu-3608 derivatives.
YU48831B (sh) Lhrh - antagonisti i postupak za njihovu proizvodnju
DE69709774D1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
HUP0004521A3 (en) Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors and medicaments containing the compounds
ES8205218A1 (es) Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo.